TNDM Q2 2024 Earnings — Tandem Diabetes Care, Inc. Revenue & Financial Results | Market Cap Arena

TNDMTandem Diabetes Care, Inc.

$1B

Q2 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$222M+13.3% YoY

Gross Profit

$113M50.8% margin

Operating Income

-$31M-13.9% margin

Net Income

-$31M-13.9% margin

EPS (Diluted)

$-0.47

QoQ Revenue Growth

+15.8%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$12M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$938M

Total Liabilities

$704M

Stockholders' Equity

$234M

Cash & Equivalents

$48M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$222M	$196M	+13.3%
Gross Profit	$113M	$102M	+10.9%
Operating Income	-$31M	-$39M	+20.7%
Net Income	-$31M	-$36M	+13.9%

Revenue Segments

Supplies and Other

$114M51%

Pump

$108M49%

Geographic Segments

UNITED STATES

$157M71%

Non-US

$65M29%